Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Corcept Therapeutics Shares Outstanding 2010-2025 | CORT

Corcept Therapeutics shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Corcept Therapeutics shares outstanding for the quarter ending March 31, 2025 were 0.120B, a 9.01% increase year-over-year.
  • Corcept Therapeutics 2024 shares outstanding were 0.113B, a 1.56% increase from 2023.
  • Corcept Therapeutics 2023 shares outstanding were 0.112B, a 3.64% decline from 2022.
  • Corcept Therapeutics 2022 shares outstanding were 0.116B, a 7.94% decline from 2021.
  
Corcept Therapeutics Annual Shares Outstanding
(Millions of Shares)
2024 113
2023 112
2022 116
2021 126
2020 124
2019 123
2018 127
2017 125
2016 116
2015 107
2014 101
2013 100
2012 93
2011 83
2010 68
2009 52
Corcept Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 120
2024-12-31 113
2024-09-30 114
2024-06-30 111
2024-03-31 110
2023-12-31 112
2023-09-30 111
2023-06-30 110
2023-03-31 115
2022-12-31 116
2022-09-30 117
2022-06-30 115
2022-03-31 115
2021-12-31 126
2021-09-30 125
2021-06-30 127
2021-03-31 130
2020-12-31 124
2020-09-30 124
2020-06-30 123
2020-03-31 122
2019-12-31 123
2019-09-30 122
2019-06-30 122
2019-03-31 124
2018-12-31 127
2018-09-30 126
2018-06-30 128
2018-03-31 128
2017-12-31 125
2017-09-30 126
2017-06-30 123
2017-03-31 121
2016-12-31 116
2016-09-30 116
2016-06-30 115
2016-03-31 110
2015-12-31 107
2015-09-30 108
2015-06-30 108
2015-03-31 102
2014-12-31 101
2014-09-30 101
2014-06-30 101
2014-03-31 101
2013-12-31 100
2013-09-30 100
2013-06-30 100
2013-03-31 100
2012-12-31 93
2012-09-30 99
2012-06-30 89
2012-03-31 84
2011-12-31 83
2011-09-30 84
2011-06-30 84
2011-03-31 81
2010-12-31 68
2010-09-30 72
2010-06-30 66
2010-03-31 63
2009-12-31 52
2009-09-30 50
2009-06-30 50
2009-03-31 50
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.555B $0.675B
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.342B 30.89
Zoetis (ZTS) United States $69.034B 25.76
Takeda Pharmaceutical (TAK) Japan $47.411B 9.43
Daiichi Sankyo, - (DSNKY) Japan $44.972B 23.05
BeOne Medicines - (ONC) Cayman Islands $27.694B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.360B 0.00
Merck (MKKGY) Germany $16.226B 11.89
Summit Therapeutics (SMMT) United States $14.972B 0.00
Shionogi (SGIOY) Japan $14.581B 14.61
United Therapeutics (UTHR) United States $13.159B 11.64
Neurocrine Biosciences (NBIX) United States $12.599B 43.16
Orion OYJ (ORINY) Finland $10.006B 27.06
IPSEN (IPSEY) France $9.836B 0.00
Stevanato Group S.p.A (STVN) Italy $7.193B 43.98
Madrigal Pharmaceuticals (MDGL) United States $6.277B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.982B 0.00
Ionis Pharmaceuticals (IONS) United States $5.890B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.000B 0.00
Hypermarcas (HYPMY) Brazil $3.132B 20.60
Crinetics Pharmaceuticals (CRNX) United States $2.856B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.782B 9.75
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.489B 13.46
BioCryst Pharmaceuticals (BCRX) United States $2.084B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.077B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.043B 0.00
Indivior (INDV) United States $1.917B 8.13
Centessa Pharmaceuticals (CNTA) United Kingdom $1.693B 0.00
Endo (NDOI) United States $1.618B 0.00
ARS Pharmaceuticals (SPRY) United States $1.563B 0.00
Evotec AG (EVO) Germany $1.410B 0.00
Ocular Therapeutix (OCUL) United States $1.327B 0.00
Guardian Pharmacy Services (GRDN) United States $1.245B 0.00
Dyne Therapeutics (DYN) United States $1.225B 0.00
Harrow (HROW) United States $1.156B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.070B 21.41
Enliven Therapeutics (ELVN) United States $1.058B 0.00
Verve Therapeutics (VERV) United States $0.991B 0.00
Collegium Pharmaceutical (COLL) United States $0.951B 5.13
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.902B 0.00
Ardelyx (ARDX) United States $0.864B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.716B 0.00
Elite Pharmaceuticals (ELTP) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.612B 0.00
Xencor (XNCR) United States $0.595B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Regulus Therapeutics (RGLS) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.567B 12.32
Altimmune (ALT) United States $0.550B 0.00
Theravance Biopharma (TBPH) United States $0.531B 0.00
Bioventus (BVS) United States $0.528B 13.40
AleAnna (ANNA) United States $0.520B 0.00
Zevra Therapeutics (ZVRA) United States $0.496B 0.00
Siga Technologies (SIGA) United States $0.459B 9.58
Amylyx Pharmaceuticals (AMLX) United States $0.455B 0.00
Oruka Therapeutics (ORKA) United States $0.449B 0.00
Tourmaline Bio (TRML) United States $0.432B 0.00
Organogenesis (ORGO) United States $0.415B 0.00
Savara (SVRA) United States $0.358B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.346B 9.35
Aquestive Therapeutics (AQST) United States $0.338B 0.00
Liminatus Pharma (LIMN) United States $0.333B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.83
Tonix Pharmaceuticals Holding (TNXP) United States $0.253B 0.00
Esperion Therapeutics (ESPR) United States $0.218B 0.00
MediWound (MDWD) Israel $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
ProKidney (PROK) United States $0.204B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
Nanobiotix S.A (NBTX) France $0.202B 0.00
OmniAb (OABI) United States $0.202B 0.00
Aldeyra Therapeutics (ALDX) United States $0.190B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Larimar Therapeutics (LRMR) United States $0.175B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.155B 0.00
Aclaris Therapeutics (ACRS) United States $0.154B 0.00
Journey Medical (DERM) United States $0.148B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.141B 0.00
VAXART, INC (VXRT) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.139B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Champions Oncology (CSBR) United States $0.116B 19.09
Protara Therapeutics (TARA) United States $0.115B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.109B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
Nektar Therapeutics (NKTR) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
Dominari Holdings (DOMH) United States $0.092B 0.00
Wellgistics Health (WGRX) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Surrozen (SRZN) United States $0.085B 0.00
Unicycive Therapeutics (UNCY) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 59.56
ESSA Pharma (EPIX) Canada $0.075B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
FibroGen (FGEN) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Ernexa Therapeutics (ERNA) United States $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.21
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00